Krystal Biotech is gearing up for a very important Q4 of 2024, because it is gearing up to report data from two different ...

"I'm a flight paramedic and former combat medic, and I wanted to create a better way to administer oxygen, nebulized ...

U.S. Supreme Court denied United Therapeutics’ petition to appeal rulings that found all claims of U.S. Patent No. 10,716,793 (‘793 Patent) were invalid Decisions that Liquidia does not infringe any ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe in the short-term (12 weeks) for reducing phlegm in COPD.

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary diseases, announced today the company will present a poster and ...

Ohtuvayre (ensifentrine) is a first-in-class selective dual inhibitor of the enzymes phosphodiesterase three and phosphodiesterase 4 (“PDE3 and PDE4”) that combines bronchodilator and non-steroidal ...

That cough was treated successfully, he said, with a regimen of nebulized (inhaled) glutathione — a treatment that’s no longer available because “this board has intimidated pharmacists in ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...